Brown Advisory Inc Abb Vie Inc. Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

A detailed history of Brown Advisory Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Brown Advisory Inc holds 820,510 shares of ABBV stock, worth $145 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

820,510

Previous 845,124 2.91%

Holding current value

$145 Million

Previous $145 Million 11.78%

% of portfolio

0.21%

Previous 0.19%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $4.03 Million - $4.91 Million	-24,614 Reduced 2.91%	820,510 $162 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $4.38 Million - $5.11 Million	28,278 Added 3.46%	845,124 $145 Million
Q1 2024 Apr 24, 2024	SELL	$159.82 - $182.1 $3.12 Million - $3.56 Million	-19,530 Reduced 2.34%	816,846 $149 Million
Q4 2023 Feb 08, 2024	BUY	$137.6 - $154.97 $319,644 - $359,995	2,323 Added 0.28%	836,376 $130 Million
Q3 2023 Oct 24, 2023	SELL	$133.59 - $154.65 $1.48 Million - $1.71 Million	-11,073 Reduced 1.31%	834,053 $124 Million
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $2 Million - $2.48 Million	-15,057 Reduced 1.75%	845,126 $114 Million
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $652,480 - $751,428	4,512 Added 0.53%	860,183 $137 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $704,274 - $844,610	-5,092 Reduced 0.59%	855,671 $138 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $2.75 Million - $3.16 Million	20,511 Added 2.44%	860,763 $116 Million
Q2 2022 Nov 14, 2022	BUY	$137.62 - $174.96 $973,936 - $1.24 Million	7,077 Added 0.85%	840,252 $129 Million
Q2 2022 Sep 13, 2022	SELL	$137.62 - $174.96 $720,440 - $915,915	-5,235 Reduced 0.6%	864,708 $132 Million
Q2 2022 Aug 02, 2022	BUY	$137.62 - $174.96 $1.7 Million - $2.16 Million	12,330 Added 1.44%	869,943 $128 Million
Q1 2022 Nov 14, 2022	SELL	$131.98 - $163.75 $4.16 Million - $5.16 Million	-31,533 Reduced 3.65%	833,175 $135 Million
Q1 2022 Sep 13, 2022	BUY	$131.98 - $163.75 $62,030 - $76,962	470 Added 0.05%	857,613 $139 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $1.43 Million - $1.78 Million	10,846 Added 1.28%	857,143 $130 Million
Q4 2021 Jan 27, 2022	BUY	$107.43 - $135.93 $1.23 Million - $1.55 Million	11,427 Added 1.37%	846,297 $115 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $5.5 Million - $6.24 Million	51,695 Added 6.6%	834,870 $90.1 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $886,289 - $987,377	8,424 Added 1.09%	783,175 $88.2 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $647,763 - $713,109	-6,332 Reduced 0.81%	774,751 $83.8 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $1.08 Million - $1.45 Million	13,366 Added 1.74%	781,083 $83.7 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $10.9 Million - $12.8 Million	126,935 Added 19.81%	767,717 $67.2 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $1.03 Million - $1.37 Million	14,001 Added 2.23%	640,782 $62.9 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $2.12 Million - $3.21 Million	32,864 Added 5.53%	626,781 $47.8 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $745,319 - $932,553	10,333 Added 1.77%	593,917 $52.6 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $358,734 - $431,301	5,696 Added 0.99%	583,584 $44.2 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $1.98 Million - $2.53 Million	-30,164 Reduced 4.96%	577,888 $42 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $2.59 Million - $3.05 Million	-33,544 Reduced 5.23%	608,052 $49 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $2.12 Million - $2.62 Million	-27,274 Reduced 4.08%	641,596 $59.1 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $499,140 - $554,887	-5,614 Reduced 0.83%	668,870 $63.3 Million
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $783,150 - $926,644	-8,723 Reduced 1.28%	674,484 $62.5 Million
Q1 2018 Jun 28, 2018	BUY	$92.01 - $123.21 $9.25 Million - $12.4 Million	100,498 Added 17.25%	683,207 $64.7 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $19.5 Million - $26.2 Million	-212,260 Reduced 26.7%	582,709 $55.2 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $2.22 Million - $2.44 Million	-24,810 Reduced 3.03%	794,969 $76.9 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $466,109 - $595,365	-6,673 Reduced 0.81%	819,779 $72.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	826,452	826,452 $59.9 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account

Brown Advisory Inc Abb Vie Inc. Transaction History